Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

By Ali H. Mokdad, E. Ford, B. Bowman, W. Dietz, F. Vinicor, V. S. Bales, J. Marks. Journal of the American Medical Association (JAMA), 2003

6,131 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/6efa98ec8421da6c7274e154ac528612ef591041

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

In Pharmacology

Jacob Seidell1

In Public Health, Environmental and Occupational Health

Citations in the corpus

The economics of obesity: dietary energy density and energy cost. (2005, background): “Although obesity rates have been increasing steadily in both sexes, at all ages, in all races, and at all educational levels (85, 91), highest rates continue to be observed among the most disadvantaged groups.”
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. (2013, background): “In the late 1990’s and early 2000s, there was a marked increase in the rate of obesity and diabetes across the globe.(3) These changes were observed and reported in the United States,(4) Europe,(5,6) Africa,(7) China,(8,9) and India.”
The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults (2006, background): “Nevertheless, because of the marked increase in the prevalence of both obesity and Type 2 diabetes, it is assumed that the prevalence of NAFLD is increasing as well.(44) One study published the results of a series of crosssectional data obtained from patients presenting for a health checkup in Japan”
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue (2009, background): “Overweight and obesity increase the risk of cardiovascular disease and type 2 diabetes mellitus (4-6) and account for a substantial proportion of global morbidity and mortality (3, 4, 7).”
Epidemiology of Obesity (2005, methodology): “One is the Behavioral Risk Factor Surveillance System, which is based on an annual telephone survey of random representative samples of the population in the United States.(6) Figure 2 shows the time trends of the prevalence of obesity in adult men and women (the two lower lines).”
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB (2005, neutral): “dtd" [ ]> Obesity is increasingly prevalent and strongly associated with the development of insulin resistanc”